Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
3.
Int Wound J ; 14(5): 791-800, 2017 Oct.
Article in English | MEDLINE | ID: mdl-27905181

ABSTRACT

Split-thickness skin grafting (STSG) is a widely used method in reconstructive surgery, but donor site wounds (DSWs) are often slow healing and painful. This prospective study evaluated the performance of a composite wound dressing containing collagen/oxidised regenerated cellulose in the treatment of medium-depth (0·4 mm) DSWs in 25 multi-morbid patients with chronic leg ulcers requiring STSG. The range of patients' ages was 44-84 years (mean 71·6 years) with DSW sizes ranging between 12 and 162 cm2 (mean 78 cm2 ). Comorbidities included anticoagulation therapy (15 patients), anaemia (11 patients), diabetes (6 patients) and methicillin-resistant Staphylococcus aureus (MRSA) ulcer colonisation (6 patients). The first dressing change was performed after 10 days. Complete reepithelialisation was observed between the 10th and 34th day (mean 17·2, median 14 days). Postoperative medium to strong bleeding occurred in only five patients (four with anticoagulation). Wound pain levels one day after harvesting were only moderate (range 0-1·5, mean 0·5, median 0·5 on a six-item scale). No wound infection was observed during the first dressing. The composite dressing used allowed for the fast healing of medium-depth DSWs with minimal or no postoperative pain and bleeding in older multi-morbid patients under anticoagulation treatment.


Subject(s)
Bandages , Headache Disorders/therapy , Leg Ulcer/therapy , Skin Transplantation/adverse effects , Surgical Wound Infection/etiology , Surgical Wound Infection/therapy , Wound Healing/physiology , Adult , Aged , Aged, 80 and over , Cellulose, Oxidized/therapeutic use , Collagen/therapeutic use , Female , Humans , Male , Middle Aged , Prospective Studies , Silver/therapeutic use
5.
J Altern Complement Med ; 17(4): 309-14, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21443446

ABSTRACT

OBJECTIVE AND METHODS: The crucial symptom of atopic eczema is itch. Acupuncture has been shown to exhibit a significant effect on experimental itch; however, studies focusing on clinical itch in atopic eczema and corresponding mechanisms are lacking. The study design was a unicenter, single-blinded (observer), prospective, randomized clinical pilot trial with an additional experimental part. In 10 patients with atopic eczema, we investigated the effect of acupuncture treatment (n = 5) compared to no treatment (n = 5) on itch intensity and in vitro basophil CD63 expression upon allergen stimulation (house dust mite and timothy grass pollen) in a pilot trial. RESULTS: Mean itch intensity in a visual analog scale was rated significantly lower in the acupuncture group (-25% ± 26% [day 15-day 0]; -24% ± 31% [day 33-day 0]) than in the control group (15% ± 6% [day 15-day 0]; 29% ± 9% [day 33-day 0]). From day 0 (before treatment) to day 15 (after 5 acupuncture treatments) as well as day 33 (after 10 acupuncture treatments), the acupuncture group showed less CD63 positive basophils than the control group regarding stimulation with house dust mite and grass pollen allergen at various concentrations (5 ng/mL, 1 ng/mL, 0.5 ng/mL, or 0.25 ng/mL). CONCLUSIONS: Our results show a reduction of itch intensity and of in vitro allergen-induced basophil activation in patients with atopic eczema after acupuncture treatment. Reducing basophil activation can be a further tool in investigating the mechanisms of action of acupuncture in immunoglobulin E-mediated allergy. Due to the limited number of patients included in our pilot trial, further studies are needed to strengthen the hypothesis.


Subject(s)
Acupuncture Therapy , Allergens/immunology , Basophils/immunology , Dermatitis, Atopic/therapy , Pruritus/therapy , Adult , Animals , Dermatitis, Atopic/complications , Dermatitis, Atopic/immunology , Dermatophagoides pteronyssinus/immunology , Female , Humans , Male , Phleum/immunology , Pilot Projects , Pruritus/etiology , Pruritus/immunology , Severity of Illness Index , Single-Blind Method , Tetraspanin 30/immunology , Young Adult
6.
Hum Mutat ; 27(6): 558-67, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16673358

ABSTRACT

The International Registry of Werner syndrome (www.wernersyndrome.org) has been providing molecular diagnosis of the Werner syndrome (WS) for the past decade. The present communication summarizes, from among 99 WS subjects, the spectrum of 50 distinct mutations discovered by our group and by others since the WRN gene (also called RECQL2 or REQ3) was first cloned in 1996; 25 of these have not previously been published. All WRN mutations reported thus far have resulted in the elimination of the nuclear localization signal at the C-terminus of the protein, precluding functional interactions in the nucleus; thus, all could be classified as null mutations. We now report two new mutations in the N-terminus that result in instability of the WRN protein. Clinical data confirm that the most penetrant phenotype is bilateral ocular cataracts. Other cardinal signs were seen in more than 95% of the cases. The median age of death, previously reported to be in the range of 46-48 years, is 54 years. Lymphoblastoid cell lines (LCLs) have been cryopreserved from the majority of our index cases, including material from nuclear pedigrees. These, as well as inducible and complemented hTERT (catalytic subunit of human telomerase) immortalized skin fibroblast cell lines are available to qualified investigators.


Subject(s)
DNA Helicases/genetics , Werner Syndrome/diagnosis , Werner Syndrome/genetics , Adult , Aged , Aged, 80 and over , Amino Acid Sequence , DNA Helicases/chemistry , DNA Mutational Analysis , Exodeoxyribonucleases , Humans , Middle Aged , Models, Molecular , Molecular Sequence Data , Pedigree , RecQ Helicases , Registries , Sequence Alignment , Werner Syndrome/mortality , Werner Syndrome Helicase
SELECTION OF CITATIONS
SEARCH DETAIL
...